News from Nashville & around the world
One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action against Omicron variants of the virus that causes COVID-19. The computational redesign approach, combined with experimental validation, could…
Looking forward to the next reporting season, however, strategists are pessimistic on the tide turning. International: Top News And Analysis
Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first phase 3, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID (LC), also known as long-haul…
About 7 percent of adults have rolled up their sleeves for the new vaccines, according to new agency data. NYT > Health
In some patients, remnants of the coronavirus in the gut may stifle production of serotonin, an important neurotransmitter, researchers suggest. NYT > Health
The physiology or medicine prize for Katalin Karikó and Drew Weissman recognized work that led to the development of vaccines that were administered to billions around the world. NYT > Health
Scientists are meeting on Tuesday to consider data on newly approved shots from Pfizer and Moderna. NYT > Health
The Food and Drug Administration approvedd new, updated COVID boosters on Monday as cases and hospitalizations rise across the United States. ABC News: Top Stories
An uptick in hospitalizations and deaths persists, but the numbers are relatively low and new vaccines are around the corner. NYT > Health
Older people are less likely to be diagnosed but more likely to experience certain kinds of illnesses, research suggests. NYT > Health
